{
  "id": 6251105,
  "title": "BioInnovation Institute injects €1.3 million each into six startups tackling cancer, disease, pest control and decarbonisation",
  "url": "https://urgent.news/2026/09/08/bioinnovation-institute-injects-1-3-million-each-into-six-startups",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-08T06:36:45.000Z",
  "source": {
    "name": "EU-Startups",
    "slug": "eu-startups",
    "url": "https://www.eu-startups.com/2026/09/bioinnovation-institute-injects-e7-8-million-into-six-startups-tackling-cancer-disease-pest-control-and-decarbonisation/"
  },
  "original_language": "en",
  "account": "Copenhagen's BioInnovation Institute (BII) has allocated €1.3 million each to six of its portfolio companies, raising the total investment per company to €1.8 million. The recipients include PanTarg, 3Sonic, Inia Biosciences, Yngvi Bio, Proxi Biotech, and Sagava. These startups previously received €500k from BII. BII's Chief Business Officer, Trine Bartholdy, praised the companies for their progress, stating that with the additional funding, they can accelerate development and move closer to market. BII, founded in 2018, supports translational research projects and life sciences and DeepTech startups through its innovation platform. Since its launch, BII has backed over 140 startups, with alumni raising more than €1 billion in external capital. In February 2026, BII secured €25 million in funding from the Novo Nordisk Foundation for its 'Upscalator' initiative to support Danish and European early-stage startups in developing novel biosolutions for the green transition. Among the six startups, PanTarg is developing an antibody-based cancer therapy, 3Sonic is creating a 3D ultrasound and AI imaging tool for surgeons, Inia Biosciences is working on treatments for inflammatory diseases, Yngvi Bio is developing biological pest control solutions, Proxi Biotech is creating a vaccine-based immunotherapy for bacterial infections, and Sagava is converting waste into sustainable biofuels for decarbonising the maritime sector.",
  "summary": "Copenhagen-based BioInnovation Institute (BII) has awarded additional convertible loans of €1.3 million each to six of its portfolio companies, bringing the total capital each has received from the institute to €1.8 million. The six recipients — PanTarg, 3Sonic, Inia Biosciences, Yngvi Bio, Proxi Biotech and Sagava — had each previously secured €500k from BII. “The […] The post BioInnovation…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}